Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer

This study has been terminated.
(The study was terminated because Cell Genesys stopped all activities for GVAX.)
Sponsor:
Collaborators:
Cell Genesys
Medarex
Information provided by (Responsible Party):
A.J.M. van den Eertwegh, VU University Medical Center
ClinicalTrials.gov Identifier:
NCT01510288
First received: January 4, 2012
Last updated: January 10, 2012
Last verified: January 2012